Medical Gas and Equipment Market by Medical Gas [(Oxygen, Nitrogen, Carbon Dioxide, Medical Air), Gas Mixtures], Equipment (Manifolds, Valves, Flowmeters), Application (Therapeutic, Diagnostic, Pharmaceutical), and End Users - Global Forecast to 2031

Market Size
$18.50B
MARKET SIZE, 2026
Projected Market Size
$24.62B
MARKET SIZE, 2031
CAGR
5.9%
CAGR (2026-2031)
Forecast Period
2026-2031
FORECAST PERIOD

MEDICAL GAS AND EQUIPMENT MARKET SIZE, SHARE & GROWTH SNAPSHOT

medical-gases-equipment-market Overview

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global medical gas and equipment market is projected to grow from USD 18.50 billion in 2026 to USD 24.62 billion by 2031, at a CAGR of 5.9% during the forecast period. The market was valued at USD 17.53 billion in 2025. The market is experiencing steady growth, driven by rising demand for advanced healthcare services across hospitals, clinics, and home care settings. On the one hand, rising rates of chronic respiratory and cardiovascular diseases, coupled with an aging population, have significantly increased demand for medical gases such as oxygen and their delivery systems. Additionally, the development and refurbishment of healthcare facilities, especially in developing countries, have facilitated the installation of new medical gas pipeline systems and equipment upgrades. Furthermore, innovations in gas delivery, monitoring, and portable equipment, along with the trend toward home healthcare and long-term oxygen therapy, are continuously driving the market forward. Altogether, these factors have been leading to the long-term growth of the medical gas and equipment market.

KEY TAKEAWAYS

  • MARKET SNAPSHOT:
    Base Year Market Size (2025): USD 17.53 Billion
    Current Market Size (2026): USD 18.50 Billion
    Forecast Market Size (2031): USD 24.62 Billion
    CAGR (2026–2031): 5.9%
  • SEGMENT LEADERSHIP:
    Regional Leader: North America accounted for the largest market share in 2025.
    Type Leader: Medical gases accounted for a larger share of 80–85% of the medical gas and equipment market in 2025.
    Application Leader: Therapeutic applications accounted for the largest market share in 2025.
    End User Leader: Hospitals & clinics held the largest share of 61–65% in 2025.
  • MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
    Air Liquide and Linde Plc were recognized as star players due to their established strong product portfolio.
    Companies such as NOVAIR USA Corp have distinguished themselves among startups and SMEs by securing strong footholds in specialized niche areas, underscoring their potential as emerging market leaders.

The medical gas and equipment market is largely driven by a rising global burden of chronic respiratory diseases (such as COPD and asthma). The US, as a key market, is fuelled by the aging population requiring long-term oxygen therapy and an increasing number of surgical and critical care procedures that use anesthetic and respiratory gases. Globally, the expansion and modernization of healthcare facilities, increased healthcare spending, and the growing trend toward home healthcare using portable oxygen concentrators and other respiratory devices are enabling demand growth.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The medical gas and equipment market plays a vital role in supporting modern healthcare by ensuring a consistent, safe, and reliable supply of essential gases and related systems across hospitals, ambulatory surgery centers, specialty clinics, and research facilities. It encompasses a broad array of products, including medical gases such as oxygen, nitrous oxide, and medical air; gas delivery devices; pipeline infrastructure; monitoring systems; and on-site gas generation solutions. Market expansion is driven by rising demand for respiratory, anesthesia, and critical care services, along with an increase in surgeries and outpatient and day care procedures. Additionally, healthcare providers are focusing more on patient safety, regulatory adherence, operational efficiency, and supply chain resilience, leading to widespread adoption of smart gas management systems, integrated pipeline solutions, and portable oxygen devices. These trends, combined with ongoing healthcare infrastructure development and technological advancements, are shaping the evolving landscape of the medical gas and equipment market.

medical-gases-equipment-market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers
Impact
Level
  • Rising demand for medical oxygen
  • Increasing number of surgeries
RESTRAINTS
Impact
Level
  • Declining reimbursements for respiratory therapies
  • Global helium shortage
OPPORTUNITIES
Impact
Level
  • Expansion of healthcare industry
  • Rising demand for pain management
CHALLENGES
Impact
Level
  • Limited availability of medical gases
  • High cost of medical gas equipment

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Driver: Rising demand for medical oxygen

The growing demand for medical oxygen is the main driver behind the expansion of the medical gas and equipment market. Medical oxygen plays a vital role in treating various health conditions, both acute and chronic. It is essential for managing diseases such as COPD, asthma, pneumonia, and cardiovascular issues, as well as supporting respiratory therapy, intensive care, anesthesia, emergency treatments, and post-surgical recovery. Factors like the increasing incidence of respiratory illnesses, an aging population, and higher hospital and ICU admissions have significantly boosted oxygen demand in healthcare settings. Additionally, the rise of home healthcare and the popularity of long-term oxygen therapy have increased the need for portable oxygen concentrators and delivery systems. Continuous investments in hospital infrastructure, on-site oxygen generation systems, and supply chain improvements further fuel the demand for medical oxygen. Overall, these factors make medical oxygen a key growth driver for the medical gas and equipment industry.

Restraint: Declining reimbursements for respiratory therapies

Lower reimbursement rates for respiratory therapies pose a major challenge to the growth of the medical gas and equipment market. Cuts in payments for oxygen therapy and related respiratory treatments directly affect their profitability. In many advanced healthcare systems, cost containment efforts by governments and private payers have led to reduced reimbursement for home oxygen, ventilatory support, and associated equipment. Consequently, hospitals, medical equipment suppliers, and home care providers are forced to cut spending on advanced gas delivery and monitoring systems. Moreover, lower reimbursements can hinder the adoption of newer, costlier respiratory devices that offer clinical benefits. As a result, market growth slows, especially in mature markets where respiratory therapies constitute a significant portion of medical gas and equipment usage.

Opportunity: Expansion of healthcare industry

The growing healthcare industry significantly drives the increased sales of medical gases and equipment. This growth is fueled by growing investments in healthcare infrastructure and the expansion of service capacities in both developed and emerging economies. The rising number of hospitals, clinics, ambulatory surgical centers, and diagnostic facilities boosts demand for medical gas pipeline systems and bulk gas storage and delivery equipment. Additionally, upgrades and capacity expansions of existing healthcare facilities help modernize and enhance safety, regulatory, and operational standards, prompting the replacement of outdated gas systems. Greater access to healthcare, increased healthcare spending, and broader insurance coverage lead to higher patient volumes. The high turnover of patients and the demand for numerous medical procedures directly increase the consumption of medical gases and related equipment. Overall, the continuous growth of the healthcare sector supports a positive market outlook and long-term growth opportunities for medical gas and equipment manufacturers and service providers.

Challenge: Limited availability of medical gases

One of the significant problems in the medical gas and equipment market is the limited availability of medical gases, especially in regions with poor healthcare infrastructure or unstable supply chains. Factors such as low production capacity, reliance on a few large factories, transportation problems, and shortages of cylinders and storage systems can disrupt the continuous supply of essential gases like oxygen and medical air. These issues become even harder during periods of increased demand, for example, during a public health crisis or when hospital admissions increase drastically, putting healthcare providers under great pressure to deliver continuous patient care. In addition, the high costs of gas production, storage, and distribution, combined with strict regulatory and safety requirements, can keep remote and low-income communities practically out of the market. Consequently, scarcity of medical gases may lead to delays in treatment and even limit overall market growth, underscoring the importance of locally manufactured solutions and stronger, more resilient supply networks.

MEDICAL GAS AND EQUIPMENT MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Air Liquide offers high-purity medical gases such as oxygen, nitrogen, nitrous oxide, and medical air that are used in hospitals, clinics, and home healthcare facilities. These gases are required for respiratory therapy, anesthesia delivery, intensive care, emergency medicine, and diagnostic procedures. The company also provides support for integrated gas pipeline systems, as well as bulk/packaged supply solutions, to ensure uninterrupted availability. Pure medical gases are essential to patient safety and clinical effectiveness because they comply with strict pharmacopoeial and regulatory standards. A reliable oxygen supply is the foundation of both acute and chronic respiratory care, while medical air and nitrogen ensure that medical devices operate safely. Consistent gas quality and supply reduce clinical risks, improve patient outcomes, and increase the hospital's operational efficiency.
Linde offers specialty medical gas mixtures, such as those containing helium. This mixture is called Heliox. Respiratory care patients with asthma, COPD, and upper airway obstruction are the primary users of Heliox. In ICUs, emergency departments, and neonatal care units, Heliox is used to minimize airway resistance and facilitate breathing. Heliox has a flow capacity greater than that of air or oxygen alone, since it is less dense. Consequently, the device can relieve respiratory distress, promote patient comfort, and potentially lessen the necessity for invasive ventilation. Also, its application is instrumental in the rapid stabilization of patients and thus achieves high productivity in acute and critical respiratory care settings.
Taiyo Nippon Sanso provides medical cryogenic gases, including liquid oxygen, liquid nitrogen, and liquid carbon dioxide, that are used for bulk hospital storage, cryosurgery, biological sample preservation, and medical research. These cryogens are the main components of large healthcare facilities, blood banks, laboratories, and biopharmaceutical applications. Cryogenic solutions provide very high-volume, low-cost gas storage with stable purity and temperature control. Liquid oxygen is used to ensure an uninterrupted supply in high-demand hospital environments, and liquid nitrogen is used for long-term storage of biological samples and for advanced medical procedures. Thus, hospital reliability is enhanced, research continuity is supported, and the overall care delivery efficiency is improved.
Air Products provides cryogenic products and storage systems that are specifically designed for healthcare and life sciences applications. This includes liquid oxygen systems for hospitals and cryogenic solutions for pharmaceutical manufacturing and laboratory use. Their equipment is capable of safely supporting the storage, vaporization, and distribution of medical gases. Cryogenic systems can ensure the secure handling of gases and provide continuous availability of these gases even during peak demand. The high degree of system reliability available most of the time, therefore, reduces the risk of system downtime and, in turn, promotes patient safety in critical care environments. Besides, effective cryogenic healthcare technology can help cut operational costs while making it easier to comply with safety and quality standards in healthcare institutions.
Atlas Copco provides medical-grade air and gas compressors, which are the main devices used to deliver medical air and support gas pipeline systems in hospitals and clinics. Such compressors are essential for ventilators, anesthesia machines, surgical tools, and other pneumatic medical equipment. Medical air compressors are the sources of clean, oil-free, and contaminant-free air that complies with healthcare standards. Their reliability ensures the uninterrupted operation of life-supporting devices; thus, maintenance requirements are lowered, and energy-saving is increased. As a result, this contributes to patient safety, makes hospital administration easier, and reduces the hospital's operational costs in the long run.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The medical gas and equipment market ecosystem is a closely connected network consisting of manufacturers, distributors, end users, and regulatory bodies. These groups work together to ensure the safe and efficient delivery of medical gases within healthcare settings. Manufacturers primarily include global industrial gas companies and equipment providers involved in producing medical gases, gas delivery systems, and related infrastructure. Distributors handle logistics, supply facilities on site, and provide after-sales support to healthcare facilities. End users such as hospitals, health systems, and specialized providers rely on a continuous gas supply to support respiratory care, anesthesia, critical care, and surgical procedures. Regulatory bodies oversee this ecosystem by establishing and enforcing standards related to quality, safety, and compliance in the production, distribution, and use of medical gases. Collectively, these interconnected players coordinate efforts to ensure smooth operations, patient safety, and reliable supply in the medical gas and equipment market.

medical-gases-equipment-market Ecosystem

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

medical-gases-equipment-market Segments

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

Medical Gas and Equipment Market, By Type

Medical gases account for the largest share in the type segment of the medical gas and equipment market due to their indispensable and continuous use across all levels of healthcare delivery. Gases such as oxygen, medical air, nitrous oxide, nitrogen, and carbon dioxide are essential for respiratory therapy, anesthesia, intensive care, emergency treatment, and a wide range of diagnostic and therapeutic procedures. Unlike equipment, which is typically purchased on a one-time or periodic replacement basis, medical gases are consumables that require an uninterrupted and recurring supply, resulting in consistently high demand. The rising prevalence of chronic respiratory and cardiovascular diseases, increasing surgical volumes, and growing ICU admissions further drive the consumption of medical gases. Additionally, the expansion of home healthcare services and long-term oxygen therapy, along with strict regulatory requirements mandating continuous gas availability in healthcare facilities, continues to reinforce the dominant share of medical gases in the medical gas and equipment market.

Medical Gas and Equipment Market, By Application

Therapeutic applications constitute the largest segment of the medical gas and equipment market, as these gases are crucial for treating various acute and chronic conditions. Gases such as oxygen, nitrous oxide, and medical air are widely used in respiratory therapy, critical care, emergency situations, anesthesia, and pain management across hospitals, clinics, and homecare settings. The growing prevalence of chronic respiratory and cardiovascular diseases, along with an aging population, has led to a significant increase in demand for therapeutic gases for long-term use. In addition, rising patient admissions, more surgical procedures, the shift towards home healthcare, and extended oxygen therapy contribute to the growing demand for therapeutic applications. Consequently, high and frequent medical gas consumption remains the primary factor behind the dominance of therapeutic uses in this market segment.

Medical Gas and Equipment Market, By End User

Hospitals and clinics account for the largest share of the medical gas and equipment market from the end-user perspective, mainly because they are at the core of delivering acute, chronic, and critical care services. These healthcare facilities experience high patient turnover and perform a wide range of medical procedures, including surgeries, emergency care, intensive care, and respiratory therapies, all of which require a continuous, reliable supply of medical gases such as oxygen, nitrous oxide, and medical air. Hospitals and clinics are major spenders on medical gas pipeline systems, bulk storage, and monitoring equipment required to support operating rooms, ICUs, neonatal units, and recovery wards. The rising prevalence of chronic diseases, increased hospital admissions, and a growing number of surgical procedures are driving higher demand from this segment. In addition, strict regulatory and safety requirements compel hospitals and clinics to maintain an uninterrupted, compliant medical gas infrastructure, which, in turn, accounts for their dominant share in the medical gas and equipment market.

REGION

Asia Pacific to be fastest-growing region in global medical gas and equipment market during forecast period

The Asia Pacific region holds the top position as the fastest-growing region in the global market for medical gases and equipment. Rapid healthcare infrastructure development and rising healthcare demand in the leading economies of China, India, and Southeast Asian countries are the main drivers of this trend. Additionally, a growing population, the rising prevalence of chronic respiratory and cardiovascular diseases, and rapid population aging are driving strong demand for medical gases and the equipment that can supply them. Governments throughout the region are making major investments in hospital construction, healthcare facility modernization, and critical care capacity expansion. Consequently, this is prompting the installation of medical gas pipeline systems and gas production equipment at the local level. This trend is further supported by improved accessibility to healthcare services, increased healthcare spending, and the growing popularity of home healthcare and long-term oxygen therapy. Moreover, the growing presence of global players in the medical gas supply sector and innovations in medical gas delivery and monitoring technologies also make it feasible for the Asia Pacific to achieve a strong position in the medical gas and equipment market.

medical-gases-equipment-market Region

MEDICAL GAS AND EQUIPMENT MARKET: COMPANY EVALUATION MATRIX

In the medical gas and equipment market matrix, Air Liquide (France) (Star) and Linde Plc (Germany) (Star) lead with their unmatched global presence, strong brand recognition, and comprehensive portfolios. Atlas Copco AB (Sweden) (Emerging Leader) is rapidly gaining traction with its versatile products, including medical gas products and equipment for various therapeutic and diagnostic applications.

medical-gases-equipment-market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

MARKET SCOPE

REPORT METRIC DETAILS
Market Size in 2025 (Value) USD 17.53 Billion
Market Forecast in 2026 (Value) USD 18.50 Billion
Market Forecast in 2031 (Value) USD 24.62 Billion
Growth Rate CAGR of 5.9% from 2026-2031
Years Considered 2024-2031
Base Year 2025
Forecast Period 2026-2031
Units Considered Value (USD Million), Volume (Thousands Units)
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends
Segments Covered
  • By Type:
    • Pure Medical Gases (Oxygen
    • Carbon Dioxide
    • Nitrogen
    • Nitrous Oxide
    • Medical Air
    • Others)
    • Medical Gas Mixtures (Blood-Gas Mixtures
    • Lung Diffusion Mixtures
    • Nitrous Oxide-Oxygen Mixtures
    • Carbon Dioxide-Oxygen Mixtures
    • Laser-Gas Mixtures
    • Anaerobic Gas Mixtures
    • Aerobic Gas Mixtures
    • Helium-Oxygen Mixtures
    • Others)
    • Medical Gas Equipment [Equipment Accessories (Vacuum Systems
    • Manifolds
    • Regulators
    • Flowmeters
    • Hoses
    • Valves with Integrated Pressure Regulators
    • Monitoring Systems
    • Medical Air Compressors
    • Other Equipment)
    • Gas Delivery Systems
    • Cryogenic Products]
  • By Application:
    • Therapeutic Applications (Respiratory Therapies
    • Cardiovascular Therapies
    • Anesthesia Delivery
    • Cryosurgery
    • Other Therapeutic Applications)
    • Pharmaceutical Manufacturing & Research
    • Diagnostic Applications (Medical Imaging
    • General Laboratory Applications)
    • Other Applications
  • By End User:
    • Hospitals & Clinics
    • Home Healthcare
    • Pharmaceutical & Biotechnology Companies
    • Academic & Research Institutions
    • Other End Users
Regions Covered  

WHAT IS IN IT FOR YOU: MEDICAL GAS AND EQUIPMENT MARKET REPORT CONTENT GUIDE

medical-gases-equipment-market Content Guide

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST CUSTOMIZATION DELIVERED VALUE ADDS
Product Analysis Further breakdown of other applications in the market Insights on other applications involved in the market
Company Information
  • Key players: Air Liquide (France), Linde plc (Ireland/Germany), Air Products and Chemicals Inc. (US), Messer SE & Co. KGaA (Germany) and Taiyo Nippon Sanso Corporation (Japan)
  • Top 3-5 players market share analysis at country level.
Insights on market share analysis by country
Geographic Analysis
  • Detailed analysis on Rest of APAC was provided to one of the top players
  • Client focused on ASEAN Market country level analysis for device market.
Country level demand mapping for new product launches and localization strategy planning

RECENT DEVELOPMENTS

  • June 2025 : ESAB Corporation (GCE) has improved its medical gas equipment portfolio by purchasing Delta P Gas Equipment, a company based in Italy, and by deciding to acquire Aktiv Technologies in India. The acquisitions allow ESAB to provide more complete medical central gas systems solutions, have a stronger global presence, and be more safety- and regulatory-compliance-oriented in their gas control equipment offering.
  • June 2024 : Messer Americas successfully completed its purchase of the Federal Helium System from the U.S. Bureau of Land Management (BLM), marking the transition of this critical national resource from federal to private ownership. The Federal Helium System, comprising the Federal Helium Reserve, the Cliffside Field and wells, the 423-mile crude helium pipeline, and related operational assets, has historically played a central role in helium supply for sectors including healthcare (e.g., MRI machines and breathing gas mixtures), research, aerospace, and manufacturing.

 

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
1
INTRODUCTION
 
 
 
 
 
35
2
EXECUTIVE SUMMARY
 
 
 
 
 
40
3
PREMIUM INSIGHTS
 
 
 
 
 
49
4
MARKET OVERVIEW
Healthcare shifts and tech advances drive medical gas demand despite regulatory and cost challenges.
 
 
 
 
 
53
 
4.1
INTRODUCTION
 
 
 
 
 
 
4.2
MARKET DYNAMICS
 
 
 
 
 
 
 
4.2.1
DRIVERS
 
 
 
 
 
 
 
4.2.1.1
INCREASING DEMAND FOR MEDICAL OXYGEN
 
 
 
 
 
 
4.2.1.2
GROWING NUMBER OF SURGERIES
 
 
 
 
 
 
4.2.1.3
EXPANSION OF GERIATRIC POPULATION AND SUBSEQUENT RISE IN CHRONIC DISEASES
 
 
 
 
 
 
4.2.1.4
SHIFT TOWARD HOME HEALTHCARE SETTINGS
 
 
 
 
 
4.2.2
RESTRAINTS
 
 
 
 
 
 
 
4.2.2.1
DECLINING REIMBURSEMENTS FOR RESPIRATORY THERAPIES
 
 
 
 
 
 
4.2.2.2
STRICT REGULATORY AND SAFETY COMPLIANCE REQUIREMENTS
 
 
 
 
 
4.2.3
OPPORTUNITIES
 
 
 
 
 
 
 
4.2.3.1
EXPANSION OF HEALTHCARE INDUSTRY
 
 
 
 
 
 
4.2.3.2
SURGE IN DEMAND FOR PAIN MANAGEMENT SOLUTIONS
 
 
 
 
 
 
4.2.3.3
GROWING ADVANCEMENTS IN HEALTHCARE TECHNOLOGIES
 
 
 
 
 
4.2.4
CHALLENGES
 
 
 
 
 
 
 
4.2.4.1
LIMITED AVAILABILITY OF MEDICAL GASES
 
 
 
 
 
 
4.2.4.2
HIGH COST OF MEDICAL GAS EQUIPMENT
 
 
 
 
4.3
UNMET NEEDS & WHITE SPACES
 
 
 
 
 
 
 
4.3.1
UNMET NEEDS IN MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
 
 
4.3.2
WHITE SPACE OPPORTUNITIES
 
 
 
 
 
4.4
INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
 
 
4.4.1
INTERCONNECTED MARKETS
 
 
 
 
 
 
4.4.2
CROSS-SECTOR OPPORTUNITIES
 
 
 
 
 
4.5
STRATEGIC MOVES BY TIER-1/2/3 PLAYERS
 
 
 
 
 
5
INDUSTRY TRENDS
Navigate industry shifts with strategic insights from competitive forces and pricing trends.
 
 
 
 
 
65
 
5.1
PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
 
5.1.1
THREAT OF NEW ENTRANTS
 
 
 
 
 
 
5.1.2
THREAT OF SUBSTITUTES
 
 
 
 
 
 
5.1.3
BARGAINING POWER OF SUPPLIERS
 
 
 
 
 
 
5.1.4
BARGAINING POWER OF BUYERS
 
 
 
 
 
 
5.1.5
INTENSITY OF COMPETITIVE RIVALRY
 
 
 
 
 
5.2
MACROECONOMIC OUTLOOK
 
 
 
 
 
 
 
5.2.1
INTRODUCTION
 
 
 
 
 
 
5.2.2
GDP TRENDS & FORECAST
 
 
 
 
 
 
5.2.3
TRENDS IN RESPIRATORY CARE DEVICES INDUSTRY
 
 
 
 
 
 
5.2.4
TRENDS IN MEDICAL NITROUS OXIDE INDUSTRY
 
 
 
 
 
5.3
SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
 
5.4
VALUE CHAIN ANALYSIS
 
 
 
 
 
 
 
5.5
ECOSYSTEM ANALYSIS
 
 
 
 
 
 
 
5.6
PRICING ANALYSIS
 
 
 
 
 
 
 
 
5.6.1
AVERAGE SELLING PRICE TREND OF MEDICAL GASES, BY KEY PLAYER (2023–2025)
 
 
 
 
 
 
5.6.2
AVERAGE SELLING PRICE TREND OF MEDICAL GASES AND EQUIPMENT, BY REGION (2023–2025)
 
 
 
 
 
5.7
TRADE DATA ANALYSIS
 
 
 
 
 
 
 
 
5.7.1
IMPORT DATA
 
 
 
 
 
 
5.7.2
EXPORT DATA
 
 
 
 
 
5.8
KEY CONFERENCES & EVENTS, 2026–2027
 
 
 
 
 
 
5.9
TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
5.10
INVESTMENT & FUNDING SCENARIO
 
 
 
 
 
 
 
5.11
CASE STUDY ANALYSIS
 
 
 
 
 
 
 
5.11.1
CASE STUDY 1: ADOPTION OF COMPUTERIZED TRACKING SYSTEM FOR IMPROVED PATIENT SAFETY AND STREAMLINED COMPLIANCE DOCUMENTATION
 
 
 
 
 
 
5.11.2
CASE STUDY 2: IMPLEMENTATION OF COMPREHENSIVE ALARM MANAGEMENT SYSTEM FOR RESPONSIBLE SURVEILLANCE
 
 
 
 
 
 
5.11.3
CASE STUDY 3: DEVELOPMENT OF PRESSURE SWING ADSORPTION PLANTS TO MEET INCREASING NEEDS OF LIQUID MEDICAL OXYGEN
 
 
 
 
 
5.12
IMPACT OF 2025 US TARIFFS ON MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
 
 
 
 
5.12.1
INTRODUCTION
 
 
 
 
 
 
5.12.2
KEY TARIFF RATES
 
 
 
 
 
 
5.12.3
PRICE IMPACT ANALYSIS
 
 
 
 
 
 
5.12.4
IMPACT ON COUNTRY/REGION
 
 
 
 
 
 
 
5.12.4.1
US
 
 
 
 
 
 
5.12.4.2
EUROPE
 
 
 
 
 
 
5.12.4.3
ASIA PACIFIC
 
 
 
 
 
 
5.12.4.4
LATIN AMERICA
 
 
 
 
 
 
5.12.4.5
MIDDLE EAST & AFRICA/GCC
 
 
 
 
 
5.12.5
IMPACT ON END USER INDUSTRIES
 
 
 
 
6
TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS
AI and digital twins revolutionize medical gas systems, paving the way for future healthcare innovation.
 
 
 
 
 
83
 
6.1
KEY EMERGING TECHNOLOGIES
 
 
 
 
 
 
 
6.1.1
SMART MEDICAL GAS MONITORING SYSTEMS
 
 
 
 
 
 
6.1.2
AI-BASED PREDICTIVE MAINTENANCE
 
 
 
 
 
 
6.1.3
DIGITAL TWIN TECHNOLOGY
 
 
 
 
 
6.2
COMPLEMENTARY TECHNOLOGIES
 
 
 
 
 
 
 
6.2.1
MEDICAL GAS PIPELINE SYSTEMS (MGPS)
 
 
 
 
 
6.3
ADJACENT TECHNOLOGIES
 
 
 
 
 
 
 
6.3.1
HEALTHCARE IOT (IOMT)
 
 
 
 
 
6.4
TECHNOLOGY/PRODUCT ROADMAP
 
 
 
 
 
 
 
6.4.1
SHORT TERM (2025–2027) | FOUNDATION & EARLY COMMERCIALIZATION
 
 
 
 
 
 
6.4.2
MID TERM (2027–2030) | EXPANSION & STANDARDIZATION
 
 
 
 
 
 
6.4.3
LONG TERM (2030–2035+) | MASS COMMERCIALIZATION & DISRUPTION
 
 
 
 
 
6.5
PATENT ANALYSIS
 
 
 
 
 
 
 
6.6
FUTURE APPLICATIONS OF MEDICAL GAS AND EQUIPMENT
 
 
 
 
 
 
6.7
IMPACT OF AI/GEN AI ON MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
 
 
 
 
6.7.1
TOP USE CASES & MARKET POTENTIAL
 
 
 
 
 
 
6.7.2
BEST PRACTICES IN MEDICAL GAS AND EQUIPMENT PROCESSING
 
 
 
 
 
 
6.7.3
CASE STUDIES OF AI IMPLEMENTATION IN MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
 
 
6.7.4
INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
6.7.5
CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
7
REGULATORY LANDSCAPE
Navigate complex global regulations with insights on compliance, standards, and eco-certifications.
 
 
 
 
 
97
 
7.1
REGIONAL REGULATIONS & COMPLIANCE
 
 
 
 
 
 
 
7.1.1
REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
7.1.2
INDUSTRY STANDARDS
 
 
 
 
 
7.2
CERTIFICATIONS, LABELING, AND ECO-STANDARDS
 
 
 
 
 
8
CUSTOMER LANDSCAPE & BUYER BEHAVIOR
Unlock revenue by understanding stakeholder influence and unmet needs in medical gas markets.
 
 
 
 
 
103
 
8.1
DECISION-MAKING PROCESS
 
 
 
 
 
 
8.2
BUYER STAKEHOLDERS & BUYING EVALUATION CRITERIA
 
 
 
 
 
 
 
8.2.1
KEY STAKEHOLDERS IN BUYING PROCESS
 
 
 
 
 
 
8.2.2
BUYING CRITERIA
 
 
 
 
 
8.3
ADOPTION BARRIERS & INTERNAL CHALLENGES
 
 
 
 
 
 
8.4
UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES
 
 
 
 
 
 
8.5
MARKET PROFITABILITY
 
 
 
 
 
 
 
8.5.1
REVENUE POTENTIAL
 
 
 
 
 
 
8.5.2
COST DYNAMICS
 
 
 
 
 
 
8.5.3
MARGIN OPPORTUNITIES IN KEY APPLICATIONS
 
 
 
 
9
MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Cubic Meters | 47 Data Tables
 
 
 
 
 
109
 
9.1
INTRODUCTION
 
 
 
 
 
 
9.2
MEDICAL GASES
 
 
 
 
 
 
 
9.2.1
PURE MEDICAL GASES
 
 
 
 
 
 
 
9.2.1.1
OXYGEN
 
 
 
 
 
 
 
 
9.2.1.1.1
INCREASING PREVALENCE OF RESPIRATORY DISEASES TO ACCELERATE GROWTH
 
 
 
 
9.2.1.2
CARBON DIOXIDE
 
 
 
 
 
 
 
 
9.2.1.2.1
EVOLVING TECHNOLOGIES AND TREATMENT METHODS IN HEALTHCARE SECTOR TO FACILITATE GROWTH
 
 
 
 
9.2.1.3
NITROGEN
 
 
 
 
 
 
 
 
9.2.1.3.1
GROWING UTILIZATION IN REPRODUCTIVE MEDICINE AND REGENERATIVE MEDICINE TO DRIVE MARKET
 
 
 
 
9.2.1.4
NITROUS OXIDE
 
 
 
 
 
 
 
 
9.2.1.4.1
INCREASING EMPHASIS ON PATIENT COMFORT TO CONTRIBUTE TO MARKET GROWTH
 
 
 
 
9.2.1.5
MEDICAL AIR
 
 
 
 
 
 
 
 
9.2.1.5.1
GROWING NEED FOR ADVANCED HEALTHCARE INFRASTRUCTURE TO BOOST MARKET
 
 
 
 
9.2.1.6
OTHER PURE MEDICAL GASES
 
 
 
 
 
9.2.2
MEDICAL GAS MIXTURES
 
 
 
 
 
 
 
9.2.2.1
BLOOD GAS MIXTURES
 
 
 
 
 
 
 
 
9.2.2.1.1
GROWING INTEGRATION WITH ELECTRONIC HEALTH RECORDS AND OTHER DIAGNOSTIC SYSTEMS TO BOOST MARKET
 
 
 
 
9.2.2.2
LUNG DIFFUSION MIXTURES
 
 
 
 
 
 
 
 
9.2.2.2.1
RISING IMPORTANCE OF EARLY DETECTION AND MANAGEMENT OF LUNG DISORDERS TO FAVOR GROWTH
 
 
 
 
9.2.2.3
NITROUS OXIDE-OXYGEN MIXTURES
 
 
 
 
 
 
 
 
9.2.2.3.1
EXPANDING ROLE IN ANESTHESIA AND PAIN MANAGEMENT TO SUSTAIN GROWTH
 
 
 
 
9.2.2.4
CARBON DIOXIDE-OXYGEN MIXTURES
 
 
 
 
 
 
 
 
9.2.2.4.1
GROWING ADOPTION OF MINIMALLY INVASIVE SURGICAL TECHNIQUES TO PROPEL MARKET
 
 
 
 
9.2.2.5
LASER GAS MIXTURES
 
 
 
 
 
 
 
 
9.2.2.5.1
INCREASING APPLICATIONS IN DERMATOLOGY, OPHTHALMOLOGY, AND ONCOLOGY TO STIMULATE GROWTH
 
 
 
 
9.2.2.6
ANAEROBIC GAS MIXTURES
 
 
 
 
 
 
 
 
9.2.2.6.1
INCREASING ADOPTION OF ADVANCED EQUIPMENT IN CLINICAL AND RESEARCH SETTINGS TO PROMOTE GROWTH
 
 
 
 
9.2.2.7
AEROBIC GAS MIXTURES
 
 
 
 
 
 
 
 
9.2.2.7.1
BOOMING GERIATRIC POPULATION AND RISING POLLUTION LEVELS TO DRIVE MARKET
 
 
 
 
9.2.2.8
HELIUM-OXYGEN MIXTURES
 
 
 
 
 
 
 
 
9.2.2.8.1
RISING BENEFITS IN EMERGENCY AND ROUTINE MEDICAL CARE TO EXPEDITE GROWTH
 
 
 
 
9.2.2.9
OTHER MEDICAL GAS MIXTURES
 
 
 
 
9.3
MEDICAL GAS EQUIPMENT
 
 
 
 
 
 
 
9.3.1
GAS DELIVERY SYSTEMS
 
 
 
 
 
 
 
9.3.1.1
RISING FOCUS ON PATIENT STABILITY AND RECOVERY TO PROMOTE GROWTH
 
 
 
 
 
9.3.2
GAS SUPPLY EQUIPMENT
 
 
 
 
 
 
 
9.3.2.1
MEDICAL GAS CYLINDERS
 
 
 
 
 
 
 
 
9.3.2.1.1
GROWING DEMAND FOR PORTABLE OXYGEN DELIVERY AND EMERGENCY MEDICAL PREPAREDNESS TO PROPEL MARKET
 
 
 
 
9.3.2.2
BULK STORAGE SYSTEMS
 
 
 
 
 
 
 
 
9.3.2.2.1
RISING HEALTHCARE INFRASTRUCTURE EXPANSION AND INCREASING MEDICAL GAS CONSUMPTION TO PROPEL MARKET
 
 
 
 
9.3.2.3
LIQUID OXYGEN SYSTEMS
 
 
 
 
 
 
 
 
9.3.2.3.1
INCREASING DEMAND FOR HIGH-VOLUME OXYGEN SUPPLY AND CRITICAL CARE SERVICES TO PROPEL MARKET
 
 
 
 
9.3.2.4
CRYOGENIC TANKS
 
 
 
 
 
 
 
 
9.3.2.4.1
GROWING ADOPTION OF CENTRALIZED MEDICAL GAS STORAGE AND RISING DEMAND FOR LARGE-CAPACITY GAS RESERVES TO PROPEL MARKET
 
 
 
 
9.3.2.5
VACUUM SYSTEMS
 
 
 
 
 
 
 
 
9.3.2.5.1
GROWING FOCUS ON INFECTION CONTROL AND COMPLEX SURGICAL THERAPIES TO PROPEL MARKET
 
 
 
 
9.3.2.6
MEDICAL AIR COMPRESSORS
 
 
 
 
 
 
 
 
9.3.2.6.1
INCREASING DEMAND FOR ADVANCED HEALTHCARE SERVICES TO AUGMENT GROWTH
 
 
 
9.3.3
GAS REGULATION & MONITORING EQUIPMENT
 
 
 
 
 
 
 
9.3.3.1
REGULATORS
 
 
 
 
 
 
 
 
9.3.3.1.1
RISING FOCUS ON TREATMENT EFFICACY AND PATIENT SAFETY TO AUGMENT GROWTH
 
 
 
 
9.3.3.2
FLOWMETERS
 
 
 
 
 
 
 
 
9.3.3.2.1
INCREASING USE IN ANESTHESIA, RESPIRATORY THERAPY, AND NEONATAL CARE APPLICATIONS TO BOOST MARKET
 
 
 
 
9.3.3.3
VALVES WITH INTEGRATED PRESSURE REGULATORS (VIPRS)
 
 
 
 
 
 
 
 
9.3.3.3.1
RISING FOCUS ON IMPROVED PATIENT CARE AND STREAMLINED OPERATIONS TO FAVOR GROWTH
 
 
 
 
9.3.3.4
PRESSURE GAUGES
 
 
 
 
 
 
 
 
9.3.3.4.1
INCREASING EMPHASIS ON MEDICAL GAS SAFETY AND REAL-TIME PRESSURE MONITORING TO PROPEL MARKET
 
 
 
 
9.3.3.5
GAS MONITORING SYSTEMS
 
 
 
 
 
 
 
 
9.3.3.5.1
NEED FOR SAFE AND EFFECTIVE DELIVERY OF MEDICAL GASES TO AID GROWTH
 
 
 
9.3.4
OTHER EQUIPMENT & ACCESSORIES
 
 
 
 
10
MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 14 Data Tables
 
 
 
 
 
159
 
10.1
INTRODUCTION
 
 
 
 
 
 
10.2
THERAPEUTIC APPLICATIONS
 
 
 
 
 
 
 
10.2.1
RESPIRATORY THERAPIES
 
 
 
 
 
 
 
10.2.1.1
INCREASING ACCESSIBILITY OF PORTABLE AND HOME-BASED RESPIRATORY THERAPY EQUIPMENT TO BOOST MARKET
 
 
 
 
 
10.2.2
CARDIOVASCULAR THERAPIES
 
 
 
 
 
 
 
10.2.2.1
SEDENTARY LIFESTYLES AND POOR DIETARY HABITS TO SUSTAIN GROWTH
 
 
 
 
 
10.2.3
ANESTHESIA DELIVERY
 
 
 
 
 
 
 
10.2.3.1
GROWING INCIDENCE OF AGE-RELATED HEALTH CONDITIONS TO FUEL MARKET
 
 
 
 
 
10.2.4
CRYOSURGERY APPLICATIONS
 
 
 
 
 
 
 
10.2.4.1
INCREASING DEMAND FOR MINIMALLY INVASIVE AND COST-EFFECTIVE TREATMENTS TO PROMOTE GROWTH
 
 
 
 
 
10.2.5
OTHER THERAPEUTIC APPLICATIONS
 
 
 
 
 
10.3
PHARMACEUTICAL MANUFACTURING & RESEARCH APPLICATIONS
 
 
 
 
 
 
 
10.3.1
BOOMING BIOPHARMACEUTICAL RESEARCH & DEVELOPMENT INITIATIVES TO ENCOURAGE GROWTH
 
 
 
 
 
10.4
DIAGNOSTIC APPLICATIONS
 
 
 
 
 
 
 
10.4.1
MEDICAL IMAGING
 
 
 
 
 
 
 
10.4.1.1
RISING DEMAND FOR HIGH-RESOLUTION IMAGING AND ADVANCED DIAGNOSTIC CAPABILITIES TO PROPEL MARKET
 
 
 
 
 
10.4.2
GENERAL LABORATORY APPLICATIONS
 
 
 
 
 
 
 
10.4.2.1
NEED FOR EFFICIENT FUNCTIONING OF EQUIPMENT AND COMPLIANCE WITH REGULATORY STANDARDS TO DRIVE MARKET
 
 
 
 
10.5
OTHER APPLICATIONS
 
 
 
 
 
11
MEDICAL GAS AND EQUIPMENT MARKET, BY END USER
Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 6 Data Tables
 
 
 
 
 
176
 
11.1
INTRODUCTION
 
 
 
 
 
 
11.2
HOSPITALS & CLINICS
 
 
 
 
 
 
 
11.2.1
BOOMING OUTPATIENT CARE AND SPECIALIZED CLINIC SERVICES TO AUGMENT GROWTH
 
 
 
 
 
11.3
HOME HEALTHCARE
 
 
 
 
 
 
 
11.3.1
GROWING SHIFT TOWARD HOME HEALTHCARE TO SUPPORT MARKET
 
 
 
 
 
11.4
PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
 
 
 
 
 
 
 
11.4.1
ONGOING ADVANCEMENTS IN PERSONALIZED MEDICINE, GENE THERAPY, AND IMMUNOTHERAPY TO ENCOURAGE GROWTH
 
 
 
 
 
11.5
ACADEMIC & RESEARCH INSTITUTIONS
 
 
 
 
 
 
 
11.5.1
GROWING IMPORTANCE OF HIGH-QUALITY EDUCATION AND TRAINING TO BOOST MARKET
 
 
 
 
 
11.6
OTHER END USERS
 
 
 
 
 
12
MEDICAL GAS AND EQUIPMENT MARKET, BY REGION
Comprehensive coverage of 8 Regions with country-level deep-dive of 14 Countries | 270 Data Tables.
 
 
 
 
 
184
 
12.1
INTRODUCTION
 
 
 
 
 
 
12.2
NORTH AMERICA
 
 
 
 
 
 
 
12.2.1
US
 
 
 
 
 
 
 
12.2.1.1
PRESENCE OF KEY PLAYERS TO SUSTAIN GROWTH
 
 
 
 
 
12.2.2
CANADA
 
 
 
 
 
 
 
12.2.2.1
STRINGENT REGULATORY COMPLIANCE TO FAVOR MARKET GROWTH
 
 
 
 
12.3
EUROPE
 
 
 
 
 
 
 
12.3.1
GERMANY
 
 
 
 
 
 
 
12.3.1.1
GROWING ADOPTION OF ADVANCED HEALTHCARE TECHNOLOGIES TO FUEL MARKET
 
 
 
 
 
12.3.2
UK
 
 
 
 
 
 
 
12.3.2.1
GROWING AGING POPULATION TO DRIVE MARKET
 
 
 
 
 
12.3.3
FRANCE
 
 
 
 
 
 
 
12.3.3.1
WELL-ESTABLISHED HEALTHCARE SYSTEM TO SUPPORT GROWTH
 
 
 
 
 
12.3.4
SPAIN
 
 
 
 
 
 
 
12.3.4.1
HIGH BURDEN OF CHRONIC DISEASES TO AUGMENT GROWTH
 
 
 
 
 
12.3.5
ITALY
 
 
 
 
 
 
 
12.3.5.1
RISING DEMAND FOR THERAPEUTIC GASES TO AID GROWTH
 
 
 
 
 
12.3.6
REST OF EUROPE
 
 
 
 
 
12.4
ASIA PACIFIC
 
 
 
 
 
 
 
12.4.1
JAPAN
 
 
 
 
 
 
 
12.4.1.1
DOMINANT ELDERLY POPULATION TO PROPEL MARKET
 
 
 
 
 
12.4.2
CHINA
 
 
 
 
 
 
 
12.4.2.1
STRONG PUBLIC HEALTHCARE INFRASTRUCTURE TO STIMULATE GROWTH
 
 
 
 
 
12.4.3
INDIA
 
 
 
 
 
 
 
12.4.3.1
GROWING INCIDENCE OF CARDIOVASCULAR DISEASES TO SPUR GROWTH
 
 
 
 
 
12.4.4
AUSTRALIA
 
 
 
 
 
 
 
12.4.4.1
ROBUST MEDICARE PROGRAM TO FACILITATE GROWTH
 
 
 
 
 
12.4.5
SOUTH KOREA
 
 
 
 
 
 
 
12.4.5.1
INCREASING CASES OF HEART DISEASE, OBESITY, CANCER, AND DIABETES TO DRIVE MARKET
 
 
 
 
 
12.4.6
REST OF ASIA PACIFIC
 
 
 
 
 
12.5
LATIN AMERICA
 
 
 
 
 
 
 
12.5.1
BRAZIL
 
 
 
 
 
 
 
12.5.1.1
INCREASING HEALTHCARE SPENDING TO CONTRIBUTE TO MARKET GROWTH
 
 
 
 
 
12.5.2
MEXICO
 
 
 
 
 
 
 
12.5.2.1
EXPANDING PHARMACEUTICAL INDUSTRY TO PROPEL MARKET
 
 
 
 
 
12.5.3
REST OF LATIN AMERICA
 
 
 
 
 
12.6
MIDDLE EAST & AFRICA
 
 
 
 
 
 
 
12.6.1
FAVORABLE GOVERNMENT INITIATIVES FOR INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET
 
 
 
 
 
 
12.6.2
GCC COUNTRIES
 
 
 
 
 
 
 
12.6.2.1
INCREASING PREVALENCE OF CARDIOVASCULAR DISEASES TO AUGMENT GROWTH
 
 
 
 
 
12.6.3
REST OF MIDDLE EAST & AFRICA
 
 
 
 
13
COMPETITIVE LANDSCAPE
Discover strategic insights and market positioning of top players in medical gas and equipment.
 
 
 
 
 
313
 
13.1
INTRODUCTION
 
 
 
 
 
 
13.2
KEY PLAYER STRATEGY/RIGHT TO WIN
 
 
 
 
 
 
 
13.2.1
OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
 
13.3
REVENUE ANALYSIS, 2021–2025
 
 
 
 
 
 
 
13.4
MARKET SHARE ANALYSIS, 2025
 
 
 
 
 
 
 
13.5
COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025
 
 
 
 
 
 
 
 
13.5.1
STARS
 
 
 
 
 
 
13.5.2
EMERGING LEADERS
 
 
 
 
 
 
13.5.3
PERVASIVE PLAYERS
 
 
 
 
 
 
13.5.4
PARTICIPANTS
 
 
 
 
 
 
13.5.5
COMPANY FOOTPRINT: KEY PLAYERS, 2025
 
 
 
 
 
 
 
13.5.5.1
COMPANY FOOTPRINT
 
 
 
 
 
 
13.5.5.2
REGION FOOTPRINT
 
 
 
 
 
 
13.5.5.3
TYPE FOOTPRINT
 
 
 
 
 
 
13.5.5.4
APPLICATION FOOTPRINT
 
 
 
 
 
 
13.5.5.5
END-USER FOOTPRINT
 
 
 
 
13.6
COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
 
13.6.1
PROGRESSIVE COMPANIES
 
 
 
 
 
 
13.6.2
RESPONSIVE COMPANIES
 
 
 
 
 
 
13.6.3
DYNAMIC COMPANIES
 
 
 
 
 
 
13.6.4
STARTING BLOCKS
 
 
 
 
 
 
13.6.5
COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
 
 
 
 
 
 
 
13.6.5.1
DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
13.6.5.2
COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
13.7
BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
 
13.8
COMPANY VALUATION & FINANCIAL METRICS
 
 
 
 
 
 
 
13.8.1
FINANCIAL METRICS
 
 
 
 
 
 
13.8.2
COMPANY VALUATION
 
 
 
 
 
13.9
COMPETITIVE SCENARIO
 
 
 
 
 
 
 
13.9.1
DEALS
 
 
 
 
 
 
13.9.2
EXPANSIONS
 
 
 
 
 
 
13.9.3
THER DEVELOPMENTS
 
 
 
 
14
COMPANY PROFILES
In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)
 
 
 
 
 
334
 
14.1
KEY PLAYERS
 
 
 
 
 
 
 
14.1.1
LINDE PLC
 
 
 
 
 
 
 
14.1.1.1
BUSINESS OVERVIEW
 
 
 
 
 
 
14.1.1.2
PRODUCTS OFFERED
 
 
 
 
 
 
14.1.1.3
RECENT DEVELOPMENTS
 
 
 
 
 
 
 
 
14.1.1.3.1
EXPANSIONS
 
 
 
 
14.1.1.4
MNM VIEW
 
 
 
 
 
 
 
 
14.1.1.4.1
RIGHT TO WIN
 
 
 
 
 
 
14.1.1.4.2
STRATEGIC CHOICES
 
 
 
 
 
 
14.1.1.4.3
WEAKNESSES & COMPETITIVE THREATS
 
 
 
14.1.2
AIR LIQUIDE
 
 
 
 
 
 
14.1.3
MESSER SE & CO. KGAA
 
 
 
 
 
 
14.1.4
AIR PRODUCTS AND CHEMICALS, INC.
 
 
 
 
 
 
14.1.5
NIPPON SANSO HOLDINGS CORPORATION
 
 
 
 
 
 
14.1.6
ATLAS COPCO AB
 
 
 
 
 
 
14.1.7
GCE GROUP
 
 
 
 
 
 
14.1.8
SOL SPA
 
 
 
 
 
 
14.1.9
ROTAREX
 
 
 
 
 
 
14.1.10
NORCO INC.
 
 
 
 
 
 
14.1.11
GENSTAR TECHNOLOGIES
 
 
 
 
 
 
14.1.12
SOUTHERN GAS LIMITED
 
 
 
 
 
 
14.1.13
DRÄGERWERK AG & CO. KGAA
 
 
 
 
 
 
14.1.14
CALOX INC.
 
 
 
 
 
 
14.1.15
PT SAMATOR INDO GAS TBK
 
 
 
 
 
14.2
OTHER PLAYERS
 
 
 
 
 
 
 
14.2.1
BUTLER GAS PRODUCTS COMPANY
 
 
 
 
 
 
14.2.2
AMICO GROUP OF COMPANIES
 
 
 
 
 
 
14.2.3
AIMS OXYGEN PVT LTD. (AOPL)
 
 
 
 
 
 
14.2.4
APEX MEDICAL GAS INC.
 
 
 
 
 
 
14.2.5
CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.
 
 
 
 
 
 
14.2.6
STEELMAN GASES PVT. LTD.
 
 
 
 
 
 
14.2.7
CARBIDE AND CHEMICALS
 
 
 
 
 
 
14.2.8
HOLSTON GASES
 
 
 
 
 
 
14.2.9
MEC MEDICAL LTD.
 
 
 
 
 
 
14.2.10
PRECISION UK
 
 
 
 
15
RESEARCH METHODOLOGY
 
 
 
 
 
390
 
15.1
RESEARCH DATA
 
 
 
 
 
 
 
15.1.1
SECONDARY DATA
 
 
 
 
 
 
 
15.1.1.1
KEY DATA FROM SECONDARY SOURCES
 
 
 
 
 
15.1.2
PRIMARY DATA
 
 
 
 
 
 
 
15.1.2.1
KEY DATA FROM PRIMARY SOURCES
 
 
 
 
 
 
15.1.2.2
KEY INDUSTRY INSIGHTS
 
 
 
 
15.2
MARKET SIZE ESTIMATION
 
 
 
 
 
 
 
15.2.1
BOTTOM-UP APPROACH
 
 
 
 
 
 
15.2.2
TOP-DOWN APPROACH
 
 
 
 
 
 
15.2.3
BASE NUMBER ESTIMATION
 
 
 
 
 
15.3
MARKET FORECAST APPROACH
 
 
 
 
 
 
15.4
MARKET BREAKDOWN & DATA TRIANGULATION
 
 
 
 
 
 
15.5
ASSUMPTIONS
 
 
 
 
 
 
 
15.5.1
MARKET SHARE ASSUMPTIONS
 
 
 
 
 
 
15.5.2
RESEARCH ASSUMPTIONS
 
 
 
 
 
15.6
FACTOR ANALYSIS
 
 
 
 
 
 
15.7
RISK ASSESSMENT
 
 
 
 
 
 
15.8
METHODOLOGY-RELATED LIMITATIONS
 
 
 
 
 
16
APPENDIX
 
 
 
 
 
403
 
16.1
DISCUSSION GUIDE
 
 
 
 
 
 
16.2
KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
 
 
 
 
 
 
16.3
CUSTOMIZATION OPTIONS
 
 
 
 
 
 
16.4
RELATED REPORTS
 
 
 
 
 
 
16.5
AUTHOR DETAILS
 
 
 
 
 
LIST OF TABLES
 
 
 
 
 
 
 
TABLE 1
MEDICAL GAS AND EQUIPMENT MARKET: INCLUSIONS & EXCLUSIONS
 
 
 
 
 
 
TABLE 2
MEDICAL GAS AND EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
TABLE 3
GDP PERCENTAGE CHANGE, BY KEY COUNTRY, 2021–2030
 
 
 
 
 
 
TABLE 4
AVERAGE SELLING PRICE TREND OF MEDICAL GASES, BY KEY PLAYER, 2023–2025 (USD MILLION)
 
 
 
 
 
 
TABLE 5
AVERAGE SELLING PRICE OF OXYGEN, BY REGION, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 6
AVERAGE SELLING PRICE OF NITROUS OXIDE, BY REGION, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 7
AVERAGE SELLING PRICE OF PORTABLE OXYGEN CONCENTRATORS, BY REGION, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 8
AVERAGE SELLING PRICE OF REGULATORS, BY REGION, 2023–2025 (USD)
 
 
 
 
 
 
TABLE 9
IMPORT DATA OF MEDICAL GAS AND EQUIPMENT FOR HS CODE 2804, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 10
EXPORT DATA OF MEDICAL GAS AND EQUIPMENT FOR HS CODE 2804, BY COUNTRY, 2021–2025 (USD THOUSAND)
 
 
 
 
 
 
TABLE 11
MEDICAL GAS AND EQUIPMENT MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS (2026–2027)
 
 
 
 
 
 
TABLE 12
US-ADJUSTED RECIPROCAL TARIFF RATES
 
 
 
 
 
 
TABLE 13
KEY PRODUCT-RELATED TARIFF EFFECTIVE FOR MEDICAL GAS AND EQUIPMENT
 
 
 
 
 
 
TABLE 14
MEDICAL GAS AND EQUIPMENT MARKET: CASE STUDIES RELATED TO AI IMPLEMENTATION
 
 
 
 
 
 
TABLE 15
INTERCONNECTED ADJACENT ECOSYSTEMS & IMPACT ON MARKET PLAYERS
 
 
 
 
 
 
TABLE 16
NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 17
EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 18
ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 19
LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 20
MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
 
 
 
 
 
 
TABLE 21
GLOBAL STANDARDS IN MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
 
 
TABLE 22
CERTIFICATIONS, LABELING, AND ECO-STANDARDS IN MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
 
 
TABLE 23
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL GAS AND EQUIPMENT, BY TYPE
 
 
 
 
 
 
TABLE 24
KEY BUYING CRITERIA FOR MEDICAL GAS AND EQUIPMENT, BY TYPE
 
 
 
 
 
 
TABLE 25
MEDICAL GAS AND EQUIPMENT MARKET: UNMET NEEDS/ END-USER EXPECTATIONS
 
 
 
 
 
 
TABLE 26
MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 27
MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 28
MEDICAL GASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 29
PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 30
PURE MEDICAL GASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 31
PURE MEDICAL GASES MARKET FOR OXYGEN, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 32
MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR OXYGEN, BY REGION, 2024–2031 (MILLION CUBIC METERS)
 
 
 
 
 
 
TABLE 33
PURE MEDICAL GASES MARKET FOR CARBON DIOXIDE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 34
MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR CARBON DIOXIDE, BY REGION, 2024–2031 (MILLION CUBIC METERS)
 
 
 
 
 
 
TABLE 35
PURE MEDICAL GASES MARKET FOR NITROGEN, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 36
MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR NITROGEN, BY REGION, 2024–2031 (MILLION CUBIC METERS)
 
 
 
 
 
 
TABLE 37
PURE MEDICAL GASES MARKET FOR NITROUS OXIDE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 38
MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR NITROUS OXIDE, BY REGION, 2024–2031 (MILLION CUBIC METERS)
 
 
 
 
 
 
TABLE 39
PURE MEDICAL GASES MARKET FOR MEDICAL AIR, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 40
MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR MEDICAL AIR, BY REGION, 2024–2031 (MILLION CUBIC METERS)
 
 
 
 
 
 
TABLE 41
OTHER PURE MEDICAL GASES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 42
MEDICAL GAS AND EQUIPMENT SYSTEMS MARKET FOR OTHER PURE MEDICAL GASES, BY REGION, 2024–2031 (MILLION CUBIC METERS)
 
 
 
 
 
 
TABLE 43
MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 44
MEDICAL GAS MIXTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 45
MEDICAL GAS MIXTURES MARKET FOR BLOOD GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 46
MEDICAL GAS MIXTURES MARKET FOR LUNG DIFFUSION MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 47
MEDICAL GAS MIXTURES MARKET FOR NITROUS OXIDE-OXYGEN MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 48
MEDICAL GAS MIXTURES MARKET FOR CARBON DIOXIDE-OXYGEN MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 49
MEDICAL GAS MIXTURES MARKET FOR LASER GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 50
MEDICAL GAS MIXTURES MARKET FOR ANAEROBIC GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 51
MEDICAL GAS MIXTURES MARKET FOR AEROBIC GAS MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 52
MEDICAL GAS MIXTURES MARKET FOR HELIUM-OXYGEN MIXTURES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 53
OTHER MEDICAL GAS MIXTURES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 54
MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 55
MEDICAL GAS EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 56
GAS DELIVERY SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 57
GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 58
GAS SUPPLY EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 59
GAS SUPPLY EQUIPMENT MARKET FOR MEDICAL GAS CYLINDERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 60
GAS SUPPLY EQUIPMENT MARKET FOR BULK STORAGE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 61
GAS SUPPLY EQUIPMENT MARKET FOR LIQUID OXYGEN SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 62
GAS SUPPLY EQUIPMENT MARKET FOR CRYOGENIC TANKS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 63
GAS SUPPLY EQUIPMENT MARKET FOR VACUUM SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 64
GAS SUPPLY EQUIPMENT MARKET FOR MEDICAL AIR COMPRESSORS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 65
GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 66
GAS REGULATION & MONITORING EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 67
GAS REGULATION & MONITORING EQUIPMENT MARKET FOR REGULATORS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 68
GAS REGULATION & MONITORING EQUIPMENT MARKET FOR FLOWMETERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 69
GAS REGULATION & MONITORING EQUIPMENT MARKET FOR VALVES WITH INTEGRATED PRESSURE REGULATORS (VIPRS), BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 70
GAS REGULATION & MONITORING EQUIPMENT MARKET FOR PRESSURE GAUGES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 71
GAS REGULATION & MONITORING EQUIPMENT MARKET FOR GAS MONITORING SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 72
OTHER EQUIPMENT & ACCESSORIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 73
MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 74
MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 75
MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 76
MEDICAL GAS AND EQUIPMENT MARKET FOR RESPIRATORY THERAPIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 77
MEDICAL GAS AND EQUIPMENT MARKET FOR CARDIOVASCULAR THERAPIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 78
MEDICAL GAS AND EQUIPMENT MARKET FOR ANESTHESIA DELIVERY, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 79
MEDICAL GAS AND EQUIPMENT MARKET FOR CRYOSURGERY APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 80
MEDICAL GAS AND EQUIPMENT MARKET FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 81
MEDICAL GAS AND EQUIPMENT MARKET FOR PHARMACEUTICAL MANUFACTURING & RESEARCH APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 82
MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 83
MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 84
MEDICAL GAS AND EQUIPMENT MARKET FOR MEDICAL IMAGING, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 85
MEDICAL GAS AND EQUIPMENT MARKET FOR GENERAL LABORATORY APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 86
MEDICAL GAS AND EQUIPMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 87
MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 88
MEDICAL GAS AND EQUIPMENT MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 89
MEDICAL GAS AND EQUIPMENT MARKET FOR HOME HEALTHCARE, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 90
MEDICAL GAS AND EQUIPMENT MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 91
MEDICAL GAS AND EQUIPMENT MARKET FOR ACADEMIC & RESEARCH INSTITUTIONS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 92
MEDICAL GAS AND EQUIPMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 93
MEDICAL GAS AND EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 94
NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 95
NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 96
NORTH AMERICA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 97
NORTH AMERICA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 98
NORTH AMERICA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 99
NORTH AMERICA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 100
NORTH AMERICA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 101
NORTH AMERICA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 102
NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 103
NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 104
NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 105
NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 106
US: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 107
US: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 108
US: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 109
US: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 110
US: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 111
US: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 112
US: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 113
US: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 114
US: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 115
US: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 116
US: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 117
CANADA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 118
CANADA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 119
CANADA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 120
CANADA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 121
CANADA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 122
CANADA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 123
CANADA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 124
CANADA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 125
CANADA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 126
CANADA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 127
CANADA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 128
EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 129
EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 130
EUROPE: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 131
EUROPE: MARKET FOR PURE MEDICAL GASES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 132
EUROPE: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 133
EUROPE: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 134
EUROPE: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 135
EUROPE: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 136
EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 137
EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 138
EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 139
EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 140
GERMANY: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 141
GERMANY: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 142
GERMANY: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 143
GERMANY: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 144
GERMANY: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 145
GERMANY: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 146
GERMANY: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 147
GERMANY: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 148
GERMANY: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 149
GERMANY: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 150
GERMANY: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 151
UK: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 152
UK: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 153
UK: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 154
UK: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 155
UK: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 156
UK: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 157
UK: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 158
UK: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 159
UK: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 160
UK: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 161
UK: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 162
FRANCE: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 163
FRANCE: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 164
FRANCE: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 165
FRANCE: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 166
FRANCE: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 167
FRANCE: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 168
FRANCE: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 169
FRANCE: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 170
FRANCE: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 171
FRANCE: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 172
FRANCE: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 173
SPAIN: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 174
SPAIN: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 175
SPAIN: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 176
SPAIN: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 177
SPAIN: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 178
SPAIN: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 179
SPAIN: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 180
SPAIN: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 181
SPAIN: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 182
SPAIN: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 183
SPAIN: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 184
ITALY: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 185
ITALY: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 186
ITALY: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 187
ITALY: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 188
ITALY: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 189
ITALY: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 190
ITALY: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 191
ITALY: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 192
ITALY: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 193
ITALY: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 194
ITALY: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 195
REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 196
REST OF EUROPE: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 197
REST OF EUROPE: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 198
REST OF EUROPE: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 199
REST OF EUROPE: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 200
REST OF EUROPE: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 201
REST OF EUROPE: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 202
REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 203
REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 204
REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 205
REST OF EUROPE: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 206
ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 207
ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 208
ASIA PACIFIC: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 209
ASIA PACIFIC: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 210
ASIA PACIFIC: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 211
ASIA PACIFIC: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 212
ASIA PACIFIC: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 213
ASIA PACIFIC: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 214
ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 215
ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 216
ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 217
ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 218
JAPAN: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 219
JAPAN: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 220
JAPAN: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 221
JAPAN: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 222
JAPAN: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 223
JAPAN: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 224
JAPAN: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 225
JAPAN: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 226
JAPAN: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 227
JAPAN: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 228
JAPAN: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 229
CHINA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 230
CHINA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 231
CHINA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 232
CHINA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 233
CHINA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 234
CHINA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 235
CHINA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 236
CHINA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 237
CHINA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 238
CHINA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 239
CHINA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 240
INDIA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 241
INDIA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 242
INDIA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 243
INDIA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 244
INDIA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 245
INDIA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 246
INDIA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 247
INDIA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 248
INDIA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 249
INDIA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 250
INDIA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 251
AUSTRALIA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 252
AUSTRALIA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 253
AUSTRALIA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 254
AUSTRALIA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 255
AUSTRALIA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 256
AUSTRALIA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 257
AUSTRALIA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 258
AUSTRALIA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 259
AUSTRALIA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 260
AUSTRALIA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 261
AUSTRALIA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 262
SOUTH KOREA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 263
SOUTH KOREA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 264
SOUTH KOREA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 265
SOUTH KOREA MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 266
SOUTH KOREA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 267
SOUTH KOREA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 268
SOUTH KOREA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 269
SOUTH KOREA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 270
SOUTH KOREA MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 271
SOUTH KOREA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 272
SOUTH KOREA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 273
REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 274
REST OF ASIA PACIFIC: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 275
REST OF ASIA PACIFIC: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 276
REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR MEDICAL GAS MIXTURES, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 277
REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR MEDICAL GAS EQUIPMENT, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 278
REST OF ASIA PACIFIC: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 279
REST OF ASIA PACIFIC: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 280
REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 281
REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 282
REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 283
REST OF ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 284
LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY COUNTRY, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 285
LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 286
LATIN AMERICA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 287
LATIN AMERICA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 288
LATIN AMERICA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 289
LATIN AMERICA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 290
LATIN AMERICA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 291
LATIN AMERICA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 292
LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 293
LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 294
LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 295
LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 296
BRAZIL: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 297
BRAZIL: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 298
BRAZIL: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 299
BRAZIL: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 300
BRAZIL: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 301
BRAZIL: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 302
BRAZIL: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 303
BRAZIL: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 304
BRAZIL: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 305
BRAZIL: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 306
BRAZIL: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 307
MEXICO: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 308
MEXICO: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 309
MEXICO: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 310
MEXICO: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 311
MEXICO: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 312
MEXICO: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 313
MEXICO: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 314
MEXICO: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 315
MEXICO: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 316
MEXICO: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 317
MEXICO: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 318
REST OF LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 319
REST OF LATIN AMERICA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 320
REST OF LATIN AMERICA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 321
REST OF LATIN AMERICA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 322
REST OF LATIN AMERICA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 323
REST OF LATIN AMERICA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 324
REST OF LATIN AMERICA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 325
REST OF LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 326
REST OF LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 327
REST OF LATIN AMERICA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 328
REST OF LATIN AMERICA MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 329
MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET, BY REGION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 330
MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 331
MIDDLE EAST & AFRICA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 332
MIDDLE EAST & AFRICA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 333
MIDDLE EAST & AFRICA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 334
MIDDLE EAST & AFRICA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 335
MIDDLE EAST & AFRICA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 336
MIDDLE EAST & AFRICA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 337
MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 338
MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 339
MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 340
MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 341
GCC COUNTRIES: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 342
GCC COUNTRIES: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 343
GCC COUNTRIES: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 344
GCC COUNTRIES: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 345
GCC COUNTRIES: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 346
GCC COUNTRIES: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 347
GCC COUNTRIES: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 348
GCC COUNTRIES: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 349
GCC COUNTRIES: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 350
GCC COUNTRIES: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 351
GCC COUNTRIES: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 352
REST OF MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 353
REST OF MIDDLE EAST & AFRICA: MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 354
REST OF MIDDLE EAST & AFRICA: PURE MEDICAL GASES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 355
REST OF MIDDLE EAST & AFRICA: MEDICAL GAS MIXTURES MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 356
REST OF MIDDLE EAST & AFRICA: MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 357
REST OF MIDDLE EAST & AFRICA: GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 358
REST OF MIDDLE EAST & AFRICA: GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 359
REST OF MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 360
REST OF MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 361
REST OF MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET FOR DIAGNOSTIC APPLICATIONS, BY TYPE, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 362
REST OF MIDDLE EAST & AFRICA: MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2024–2031 (USD MILLION)
 
 
 
 
 
 
TABLE 363
OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
 
 
TABLE 364
MEDICAL GAS AND EQUIPMENT MARKET: DEGREE OF COMPETITION
 
 
 
 
 
 
TABLE 365
MEDICAL GAS AND EQUIPMENT MARKET: REGION FOOTPRINT
 
 
 
 
 
 
TABLE 366
MEDICAL GAS AND EQUIPMENT MARKET: TYPE FOOTPRINT
 
 
 
 
 
 
TABLE 367
MEDICAL GAS AND EQUIPMENT MARKET: APPLICATION FOOTPRINT
 
 
 
 
 
 
TABLE 368
MEDICAL GAS AND EQUIPMENT MARKET: END-USER FOOTPRINT
 
 
 
 
 
 
TABLE 369
MEDICAL GAS AND EQUIPMENT MARKET: DETAILED LIST OF KEY STARTUPS/SMES
 
 
 
 
 
 
TABLE 370
MEDICAL GAS AND EQUIPMENT MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
 
 
 
 
 
 
TABLE 371
MEDICAL GAS AND EQUIPMENT MARKET: DEALS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 372
MEDICAL GAS AND EQUIPMENT MARKET: EXPANSIONS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 373
MEDICAL GAS AND EQUIPMENT MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 374
LINDE PLC: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 375
LINDE PLC: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 376
LINDE PLC: EXPANSIONS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 377
AIR LIQUIDE: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 378
AIR LIQUIDE: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 379
AIR LIQUIDE: DEALS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 380
AIR LIQUIDE: EXPANSIONS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 381
AIR LIQUIDE: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 382
MESSER SE & CO. KGAA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 383
MESSER SE & CO. KGAA: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 384
MESSER SE & CO. KGAA: DEALS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 385
MESSER SE & CO. KGAA: EXPANSIONS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 386
AIR PRODUCTS AND CHEMICALS, INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 387
AIR PRODUCTS AND CHEMICALS, INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 388
NIPPON SANSO HOLDINGS CORPORATION: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 389
NIPPON SANSO HOLDINGS CORPORATION: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 390
NIPPON SANSO HOLDINGS CORPORATION: DEALS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 391
ATLAS COPCO AB: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 392
ATLAS COPCO AB: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 393
ATLAS COPCO AB: DEALS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 394
GCE GROUP: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 395
GCE GROUP: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 396
GCE GROUP: DEALS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 397
SOL SPA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 398
SOL SPA: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 399
SOL SPA: DEALS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 400
MEDTRONIC PLC: EXPANSIONS, JANUARY 2021–JUNE 2026
 
 
 
 
 
 
TABLE 401
ROTAREX: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 402
ROTAREX: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 403
NORCO INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 404
NORCO INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 405
GENSTAR TECHNOLOGIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 406
GENSTAR TECHNOLOGIES: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 407
SOUTHERN GAS LIMITED: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 408
SOUTHERN GAS LIMITED: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 409
DRÄGERWERK AG & CO. KGAA: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 410
DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 411
CALOX INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 412
CALOX INC.: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 413
PT SAMATOR INDO GAS TBK: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 414
PT SAMATOR INDO GAS TBK: PRODUCTS OFFERED
 
 
 
 
 
 
TABLE 415
BUTLER GAS PRODUCTS COMPANY: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 416
AMICO GROUP OF COMPANIES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 417
AIMS OXYGEN PVT LTD. (AOPL): COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 418
APEX MEDICAL GAS INC.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 419
CHENGDU TAIYO INDUSTRIAL GASES CO., LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 420
STEELMAN GASES PVT. LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 421
CARBIDE AND CHEMICALS: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 422
HOLSTON GASES: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 423
MEC MEDICAL LTD.: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 424
PRECISION UK: COMPANY OVERVIEW
 
 
 
 
 
 
TABLE 425
RISK ASSESSMENT: MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
 
 
LIST OF FIGURES
 
 
 
 
 
 
 
FIGURE 1
MEDICAL GAS AND EQUIPMENT MARKET SEGMENTATION & REGIONAL SCOPE
 
 
 
 
 
 
FIGURE 2
MEDICAL GAS AND EQUIPMENT MARKET: YEARS CONSIDERED
 
 
 
 
 
 
FIGURE 3
KEY INSIGHTS & MARKET HIGHLIGHTS
 
 
 
 
 
 
FIGURE 4
MEDICAL GAS AND EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
 
 
 
 
 
 
FIGURE 5
PURE MEDICAL GASES MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
 
 
 
 
 
 
FIGURE 6
MEDICAL GAS MIXTURES MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
 
 
 
 
 
 
FIGURE 7
MEDICAL GAS EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
 
 
 
 
 
 
FIGURE 8
GAS SUPPLY EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
 
 
 
 
 
 
FIGURE 9
GAS REGULATION & MONITORING EQUIPMENT MARKET, BY TYPE, 2026 VS. 2031 (USD MILLION)
 
 
 
 
 
 
FIGURE 10
MEDICAL GAS AND EQUIPMENT MARKET, BY APPLICATION, 2026 VS. 2031 (USD MILLION)
 
 
 
 
 
 
FIGURE 11
MEDICAL GAS AND EQUIPMENT MARKET, BY END USER, 2026 VS. 2031 (USD MILLION)
 
 
 
 
 
 
FIGURE 12
MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
 
 
FIGURE 13
DISRUPTIVE TRENDS IMPACTING GROWTH OF MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
 
 
FIGURE 14
HIGH-GROWTH SEGMENTS & EMERGING FRONTIERS IN MEDICAL GAS AND EQUIPMENT MARKET
 
 
 
 
 
 
FIGURE 15
ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 16
INCREASING HEALTHCARE EXPENDITURE AND PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
 
 
 
 
 
 
FIGURE 17
JAPAN AND MEDICAL GASES SEGMENT DOMINATED MARKET IN 2025
 
 
 
 
 
 
FIGURE 18
NORTH AMERICA TO LEAD MARKET DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 19
INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 20
DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
 
 
 
 
 
 
FIGURE 21
MEDICAL GAS AND EQUIPMENT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
 
 
 
 
 
 
FIGURE 22
GLOBAL GERIATRIC POPULATION, BY REGION, 2010 VS. 2015 VS. 2030 (% OF TOTAL POPULATION)
 
 
 
 
 
 
FIGURE 23
PREVALENCE OF CHRONIC PAIN AND HIGH-IMPACT CHRONIC PAIN AMONG ADULTS IN US, 2019–2021
 
 
 
 
 
 
FIGURE 24
MEDICAL GAS AND EQUIPMENT MARKET: PORTER’S FIVE FORCES ANALYSIS
 
 
 
 
 
 
FIGURE 25
MEDICAL GAS AND EQUIPMENT MARKET: SUPPLY CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 26
MEDICAL GAS AND EQUIPMENT MARKET: VALUE CHAIN ANALYSIS
 
 
 
 
 
 
FIGURE 27
MEDICAL GAS AND EQUIPMENT MARKET: ECOSYSTEM ANALYSIS
 
 
 
 
 
 
FIGURE 28
MEDICAL GAS AND EQUIPMENT MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
 
 
 
 
 
 
FIGURE 29
INVESTMENT/VENTURE CAPITAL SCENARIO IN MEDICAL GAS AND EQUIPMENT MARKET, 2020–2023
 
 
 
 
 
 
FIGURE 30
TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR MEDICAL GAS AND EQUIPMENT MARKET (JANUARY 2016–MAY 2026)
 
 
 
 
 
 
FIGURE 31
TOP PATENT APPLICANT COUNTRIES FOR MEDICAL GAS AND EQUIPMENT (JANUARY 2016–MAY 2026)
 
 
 
 
 
 
FIGURE 32
INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR MEDICAL GAS AND EQUIPMENT, BY TYPE
 
 
 
 
 
 
FIGURE 33
KEY BUYING CRITERIA FOR MEDICAL GAS AND EQUIPMENT, BY TYPE
 
 
 
 
 
 
FIGURE 34
NORTH AMERICA: MEDICAL GAS AND EQUIPMENT MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 35
ASIA PACIFIC: MEDICAL GAS AND EQUIPMENT MARKET SNAPSHOT
 
 
 
 
 
 
FIGURE 36
REVENUE ANALYSIS OF KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET (2021−2025)
 
 
 
 
 
 
FIGURE 37
MARKET SHARE ANALYSIS OF KEY PLAYERS IN MEDICAL GAS AND EQUIPMENT MARKET (2025)
 
 
 
 
 
 
FIGURE 38
MEDICAL GAS AND EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025
 
 
 
 
 
 
FIGURE 39
MEDICAL GAS AND EQUIPMENT MARKET: COMPANY FOOTPRINT
 
 
 
 
 
 
FIGURE 40
MEDICAL GAS AND EQUIPMENT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025
 
 
 
 
 
 
FIGURE 41
MEDICAL GAS AND EQUIPMENT MARKET: BRAND/PRODUCT COMPARISON
 
 
 
 
 
 
FIGURE 42
EV/EBITDA OF KEY VENDORS
 
 
 
 
 
 
FIGURE 43
YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDOR
 
 
 
 
 
 
FIGURE 44
LINDE PLC: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 45
AIR LIQUIDE: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 46
MESSER SE & CO. KGAA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 47
AIR PRODUCTS AND CHEMICALS, INC.: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 48
NIPPON SANSO HOLDINGS CORPORATION: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 49
ATLAS COPCO AB: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 50
SOL SPA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 51
SOUTHERN GAS LIMITED: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 52
DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 53
PT SAMATOR INDO GAS TBK: COMPANY SNAPSHOT (2025)
 
 
 
 
 
 
FIGURE 54
RESEARCH DESIGN
 
 
 
 
 
 
FIGURE 55
PRIMARY SOURCES
 
 
 
 
 
 
FIGURE 56
BOTTOM-UP APPROACH
 
 
 
 
 
 
FIGURE 57
TOP-DOWN APPROACH
 
 
 
 
 
 
FIGURE 58
SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
 
 
 
 
 
 
FIGURE 59
REVENUE SHARE ANALYSIS ILLUSTRATION: LINDE PLC
 
 
 
 
 
 
FIGURE 60
MEDICAL GAS AND EQUIPMENT MARKET: SUPPLY-SIDE MARKET ESTIMATION (2025)
 
 
 
 
 
 
FIGURE 61
CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
 
 
 
 
 
 
FIGURE 62
MARKET DATA TRIANGULATION METHODOLOGY
 
 
 
 
 
 

 

Methodology

This study involved four major activities in estimating the current medical gas and equipment market size. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

Secondary Research

The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the medical gas and equipment market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the medical gas and equipment market. The primary sources on the demand side included industry experts, purchasing and sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

A breakdown of the primary respondents for the medical gas and equipment market is provided below:

Medical Gas and Equipment Market 
 Size, and Share

Note 1: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 2: Other designations include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

Note 3: Companies are classified into tiers based on their total revenue. Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

To know about the assumptions considered for the study, download the pdf brochure

Market Estimation Methodology

For the global market value, annual revenues were calculated using revenue mappings of major product manufacturers and OEMs active in the global medical gas and equipment market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/sub-segments was done for the major players. Also, the global medical gas and equipment market was split into various segments and sub-segments based on:

  • List of major players operating in the products market at the regional and/or country level
  • Product mapping of various medical gas and equipment manufacturers at the regional and/or country level
  • Mapping of annual revenue generated by listed major players from medical gas and equipment (or the nearest reported business unit/product category)
  • Revenue mapping of major players
  • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
  • Summation of the market value of all segments/subsegments to arrive at the global medical gas and equipment market

The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

Medical Gas and Equipment Market Top Down and Bottom Up Approach

Data Triangulation

After arriving at the overall size of the global medical gas and equipment market through the above-mentioned methodology, this market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

Market Definition

Medical gases and equipment are significant elements in medical centers (such as acute care, hospitals, surgery centers, and emergency medical services), life sciences (pharmaceutical, biotech, and life science R&D), long-term care (like nursing homes and home healthcare), and laboratories (including analytical, commercial, life sciences, and university laboratories). The market covers medical pure gases, medical gas mixtures, and various equipment used for the storage, transportation, and delivery of medical gases.

Key Stakeholders

  • Medical gas manufacturers
  • Medical gases equipment manufacturing companies
  • Medical gases and equipment distributors
  • Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)
  • Pharmaceutical and biotechnology companies
  • Research institutes and academic centers
  • Contract research organizations (CROs)
  • Government associations
  • Home-healthcare services providers
  • Market research and consulting firms
  • Venture capitalists and investors

Objectives of the Study

  • To describe, analyze, and forecast the medical gas and equipment market by type, application, end user and region
  • To describe and forecast the medical gas and equipment market for key regions—North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
  • To provide detailed information regarding the drivers, restraints, opportunities, and challenges influencing the growth of the medical gas and equipment market
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To profile key players and comprehensively analyze their market shares and core competencies2 in the medical gas and equipment market
  • To analyze competitive developments such as partnerships, collaborations, agreements & acquisitions, product launches, expansions, and R&D activities in the medical gas and equipment market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

GEOGRAPHIC ANALYSIS

  • Further breakdown of the Rest of Europe medical gas and equipment market into Russia, Switzerland, Denmark, Austria, and others
  • Further breakdown of the Rest of Asia Pacific medical gas and equipment market into South Korea, Taiwan, and others
  • Further breakdown of the Rest of Latin America medical gas and equipment market into Argentina, Colombia, Chile, Ecuador, and others
  • Further breakdown of the Southeast Asia medical gas and equipment market into Malaysia, Singapore, New Zealand, and others

COMPETITIVE LANDSCAPE ASSESSMENT

  • Market share analysis, by region (North America and Europe), which provides market shares of the top 3-5 key players in the medical gas and equipment market
  • Competitive leadership mapping for established players in the US

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Medical Gas and Equipment Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

TESTIMONIALS

Growth opportunities and latent adjacency in Medical Gas and Equipment Market

Daniel

Apr, 2026

We are exploring physical AI in healthcare devices. Which segments are seeing early adoption?.

Ethan

Apr, 2026

From a hospital procurement standpoint, how do you evaluate the ROI of investing in centralized medical gas pipeline systems versus standalone cylinders?.

Madison

Apr, 2026

What are the key adoption challenges for advanced medical gas equipment in emerging healthcare markets?.

Logan

Apr, 2026

How scalable is the medical gases equipment market, especially with rising demand from home healthcare and ambulatory settings?.

Harper

Apr, 2026

How do you see integration challenges between medical gas systems and hospital digital infrastructure?.

Owen

Apr, 2026

What future opportunities do you see shaping the medical gases and equipment market over the next decade?.

DMCA.com Protection Status